glp-1 skin sensitivity Dermal Hypersensitivity Reaction to Semaglutide: Two Case Reports glp-1 skin sensitivity A Closer

Ongoing difficulty concentrating, mood swings, or memory concerns should be discussed with a clinician

Role of underlying medical pathology contributing to premature hair graying In contrast to physiologic aging, premature graying may also be influenced by underlying health conditions that disrupt the normal pigmentation process

Key results at the highest dose (24 mg): 22.5% placebo-adjusted mean weight loss at 48 weeks 96% achieved at least 5% weight loss 87% achieved at least 10% weight loss 48% achieved at least 20% weight loss 26% achieved at least 30% weight loss 54% reduced BMI below the obesity threshold (30 kg/m2) versus 13% placebo No weight loss plateau at 48 weeks Discontinuation due to adverse events: 5.9% (CT-388) vs 1.3% (placebo) Preclinical Data# CT-388 improved glycemic control in mice and monkeys, reduced body weight, suppressed appetite, and improved metabolic dysfunction-associated steatohepatitis (MASH) pathology in mice

They have not been evaluated by the U.S

Heavy drinkers should consult a healthcare professional for personalized guidance

Should Medicare and Medicaid expand to cover weight loss drugs